In the Fall semester of my third year at Osgoode Hall Law School, I had the opportunity to take part in the Intellectual Property Law and Technology Intensive Program. This…
Tag: AstraZeneca
IP Intensive: Sitting at the Crossroads of Law, Medicine, Business, and Government - A Semester at AstraZeneca
I was thrilled when I found out I’d be joining the legal team at AstraZeneca Canada for a semester, as part of Osgoode’s IP Law and Technology Intensive Program. I…
IP Intensive: The Business of Innovation - A Semester at AstraZeneca
As part of Osgoode’s IP Law and Technology Intensive Program, I had the amazing opportunity to serve a 10-week internship at AstraZeneca Canada under the supervision of AstraZeneca’s Legal Director,…
IP Intensive: AstraZeneca visits the Supreme Court of Canada
As part of Osgoode’s Intellectual Property Law & Technology Intensive Program, I had the distinct pleasure of working with the Legal Affairs team at AstraZeneca Canada. With a technical background…
IP Intensive: A Semester at AstraZeneca Canada
Last semester, as part of Osgoode’s Intellectual Property Law and Technology Intensive Program, I had the opportunity to work with in-house counsel at AstraZeneca Canada. Having previously completed graduate studies…
An Unexpected Infringement: There and Back Again
On March 16, 2015, Justice Barnes held that AstraZeneca’s Patent No 1,292,693 (“’693 Patent”), a formulation patent for omeprazole, was valid and infringed by Apotex (2015 FC 322). This decision…